Rhenman & Partners Asset Management AB

Holdings History for Edwards Lifesciences Corp - Common Stock (EW)

Symbol: EW on NYSE
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.5%	+0.31%	$16,495,875	193,500	+38,500	+25%	$85.25	Q4 2025
30 Sep 2025	1.3%	+0.86%	$12,054,350	155,000	+100,000	+182%	$77.77	Q3 2025
30 Jun 2025	0.54%	+0.54%	$4,301,550	55,000	+55,000	NEW	$78.21	Q2 2025
30 Sep 2024		-0.86%	$0	0	-97,500	-100%	$78.71	Q3 2024
30 Jun 2024	0.86%	+0.85%	$9,006,075	97,500	+97,500	NEW	$92.37	Q2 2024
31 Dec 2023		-0.22%	$0	0	-29,000	-100%	$78.71	Q4 2023
30 Sep 2023	0.22%	0%	$2,009,120	29,000	0		$69.28	Q3 2023
30 Jun 2023	0.29%	-0.41%	$2,735,570	29,000	-41,000	-59%	$94.33	Q2 2023
31 Mar 2023	0.63%	-0.66%	$5,709,900	70,000	-74,000	-51%	$81.57	Q1 2023
31 Dec 2022	1.1%	+0.15%	$10,743,840	144,000	+19,000	+15%	$74.61	Q4 2022
30 Sep 2022	1%	+0.67%	$9,054,000	125,000	+80,000	+178%	$72.43	Q3 2022
30 Jun 2022	0.49%	-0.22%	$4,279,000	45,000	-20,000	-31%	$95.09	Q2 2022
31 Mar 2022	0.75%	-0.41%	$7,652,000	65,000	-35,000	-35%	$117.72	Q1 2022
31 Dec 2021	0.87%	-0.04%	$13,068,000	100,000	-5,000	-4.8%	$130.68	Q4 2021
30 Sep 2021	0.83%	-0.04%	$11,887,000	105,000	-5,000	-4.5%	$113.21	Q3 2021
30 Jun 2021	0.77%	0%	$11,393,000	110,000	0		$103.57	Q2 2021
31 Mar 2021	0.64%	-0.09%	$9,200,000	110,000	-15,000	-12%	$83.64	Q1 2021
31 Dec 2020	0.93%	+0.04%	$11,404,000	125,000	+5,000	+4.2%	$91.23	Q4 2020
30 Sep 2020	0.85%	0%	$9,578,000	120,000	0		$79.82	Q3 2020
30 Jun 2020	0.9%	+0.47%	$8,293,000	120,000	+63,000	+111%	$69.11	Q2 2020
31 Mar 2020	1.5%	+0.5%	$10,751,000	57,000	+19,000	+50%	$188.61	Q1 2020
31 Dec 2019	0.97%	+0.04%	$8,865,000	38,000	+1,415	+3.9%	$233.29	Q4 2019
30 Sep 2019	1%	+0.14%	$8,045,000	36,585	+5,000	+16%	$219.90	Q3 2019
30 Jun 2019	0.66%	+0.1%	$5,835,000	31,585	+5,000	+19%	$184.74	Q2 2019
31 Mar 2019	0.6%	-0.9%	$5,087,000	26,585	-40,000	-60%	$191.35	Q1 2019
31 Dec 2018	1.2%	-0.53%	$10,199,000	66,585	-30,000	-31%	$153.17	Q4 2018
30 Sep 2018	1.7%	+0.49%	$16,815,000	96,585	+28,221	+41%	$174.10	Q3 2018
30 Jun 2018	1%	-0.22%	$9,952,000	68,364	-15,000	-18%	$145.57	Q2 2018
31 Mar 2018	1.4%	+0.17%	$11,631,000	83,364	+10,000	+14%	$139.52	Q1 2018
31 Dec 2017	1.1%	-0.1%	$8,269,000	73,364	-6,636	-8.3%	$112.71	Q4 2017
30 Sep 2017	1.1%	+0.66%	$8,745,000	80,000	+47,000	+142%	$109.31	Q3 2017
30 Jun 2017	0.56%	-0.46%	$3,902,000	33,000	-27,000	-45%	$118.24	Q2 2017
31 Mar 2017	0.89%	-0.15%	$5,644,000	60,000	-10,000	-14%	$94.07	Q1 2017
31 Dec 2016	1.3%	+0.27%	$6,559,000	70,000	+15,000	+27%	$93.70	Q4 2016
30 Sep 2016	1.1%	-0.3%	$6,630,800	55,000	-15,000	-21%	$120.56	Q3 2016
30 Jun 2016	1.2%	+0.27%	$6,981,000	70,000	+15,000	+27%	$99.73	Q2 2016
31 Mar 2016	0.96%	+0.11%	$4,852,000	55,000	+6,000	+12%	$88.22	Q1 2016
31 Dec 2015	0.59%	-0.16%	$3,870,000	49,000	-13,000	-21%	$78.98	Q4 2015
30 Sep 2015	1.4%	+0.77%	$8,815,000	62,000	+34,000	+121%	$142.18	Q3 2015
30 Jun 2015	0.56%	+0.18%	$3,988,000	28,000	+9,000	+47%	$142.43	Q2 2015
31 Mar 2015	0.48%	0%	$2,707,000	19,000	0		$142.47	Q1 2015
31 Dec 2014	0.72%	-0.04%	$2,420,000	19,000	-1,000	-5%	$127.37	Q4 2014
30 Sep 2014	0.63%	-0.47%	$2,043,000	20,000	-15,000	-43%	$102.15	Q3 2014
30 Jun 2014	0.89%	-0.28%	$3,004,000	35,000	-11,187	-24%	$85.83	Q2 2014
31 Mar 2014	1.1%	+1.1%	$3,426,000	46,187	+46,187	NEW	$74.18	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.